Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
unimore.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
☰
Pubblicazioni
BLOOD ADVANCES
Rivista
Codice:
E247527
ISSN:
2473-9529
Dati Generali
Dati Generali
Pubblicazioni (36)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells
Articolo
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
Articolo
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project
Articolo
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs
Articolo
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
Articolo
Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax
Articolo
Are the available data sufficient to suggest cytoreductive agents for patients with CHIP and stroke?
Articolo
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Articolo
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Articolo
Correction of b-thalassemia by CRISPR/Cas9 editing of the a-globin locus in human hematopoietic stem cells
Articolo
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
Articolo
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
Articolo
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
Articolo
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma
Articolo
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion
Articolo
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Articolo
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML
Articolo
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency
Articolo
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph1 acute lymphoblastic leukemia
Articolo
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia
Articolo
Identification of a murine CD45-F4/80lo HSC-derived marrow endosteal cell associated with donor stem cell engraftment
Articolo
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide
Articolo
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study
Articolo
Large-scale circular RNA deregulation in T-ALL: Unlocking unique ectopic expression of molecular subtypes
Articolo
Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
Articolo
Leukocytosis and thrombosis in polycythemia vera: can clinical trials settle the debate?
Articolo
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
Articolo
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
Articolo
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
Articolo
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
Articolo
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort
Articolo
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: A multicenter Italian study
Articolo
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial
Articolo
Ruxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis
Articolo
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
Articolo
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
